Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Three Brain Tumor Research Grant Funding Opportunities Open Today

American Brain Tumor Association
Posted on: 27 Aug 16

CHICAGO, Aug. 24, 2016 /PRNewswire-USNewswire/ -- The American Brain Tumor Association (ABTA) is now accepting letters of intent for three research funding opportunities beginning today, August 24. ABTA-funded research projects have supported novel and high-impact projects in brain tumors. Request for funding applications are accepted until Wednesday, October 5, 2016 at 12:00 noon Central Daylight Time.

More than four decades of the ABTA's research support has led to a better understanding of the genetic makeup, signaling and microenvironment of brain tumors; new drug development and novel treatments; and helped to enhance quality of life for brain tumor patients.

"The ABTA has funded nearly $30 million in brain tumor research," said Nicole Willmarth, PhD, chief science officer, American Brain Tumor Association. "We are proud to provide these opportunities to support early-career investigators and innovative brain tumor research projects through these grant mechanisms, especially as discoveries in science and technology are moving at an unprecedented pace."

Eligible researchers have three funding opportunities available, including:

Research Collaboration Grants: These grants are the ABTA's newest funding mechanism and provide two-year, $200,000 grants intended to promote team science in order to streamline and accelerate progress and effect the desired change in clinical outcome for brain tumors. The research projects supported under this mechanism must be conducted by a team of at least two co-principal investigators from separate research institutions. To be considered multi-disciplinary in approach, research projects should investigate multiple components, such as basic, translational, clinical and epidemiological research.

Basic Research Fellowships: These two-year, $100,000 grants support postdoctoral fellows conducting brain tumor research. Fellows must include a lead mentor who currently conducts brain tumor research at the same academic institution in an effort to provide the research, scientific, management and other leadership guidance necessary to foster the applicant's career advancement. Beginning in 2016, Basic Research Fellowships will require a letter of intent.

Discovery Grants: These one-year, $50,000 grants are for investigators conducting high-risk/high-impact research deemed to have the potential to change current diagnostic or treatment paradigms for adults and children with brain tumors. Investigators from sciences outside traditional biology fields are encouraged to apply. The Discovery Grant Program also requires a letter of intent (LOI). Submission of discovery-driven science and proof-of-concept studies are encouraged, particularly for concepts with little or no history of previous funding.

Research projects under the ABTA Research Collaboration, Basic and Discovery Grant Programs are all pre-screened using an LOI mechanism.

For more information about the American Brain Tumor Association's research program and grant funding opportunities, visit www.abta.org/grants.

About the American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association was the first and is the only national patient advocacy organization committed to funding brain tumor research and providing support and education programs for people of all tumor types and all ages.

For more information, visit www.abta.org or call 800-886-ABTA (2282).

MEDIA CONTACT:
Phung Tran
773-577-8791
ptran@abta.org

RESEARCH CONTACT:
Natalie Alvarado
773-577-8742
grants@abta.org

Logo - http://photos.prnewswire.com/prnh/20150901/262855LOGO

 

SOURCE American Brain Tumor Association

For more information:
www.abta.org

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 27/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.